Latest Bristol-Myers Squibb Stories

2012-08-29 07:00:20

Connie K. Ho for redOrbit.com – Your Universe Online The Food and Drug Administration (FDA) recently approved the sale and distribution of Stribild, an HIV medication that includes four different drugs in one pill. The FDA believes that Stribild offers complete treatment for infections related to HIV. The cost of the drug is about $28,500 for a year’s supply, which gives manufacturer Gilead Sciences Inc. unlimited pricing power as the company retains ownership of all the ingredients...

Insider Hot Stocks: Autodesk, JPMorgan, Symantec, Bristol Myers Squibb, Petroleo Brasileiro SA, and USG

2012-08-27 02:30:53

VANCOUVER, British Columbia, Aug. 27, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Autodesk (NASDAQ:ADSK), JPMorgan (NYSE:JPM), Symantec (NASDAQ:SYMC), Bristol Myers Squibb (NYSE:BMY), Petroleo Brasileiro SA (NYSE:PBR.A), and USG (NYSE:USG). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to...

Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohn's Disease

2012-08-27 02:25:01

BOTHELL, Wash., Aug. 27, 2012 /PRNewswire/ -- Alder Biopharmaceuticals Inc. today announced it has received a $3.5 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2 clinical trial of ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6), in Crohn's disease. The milestone payment is part of the collaboration between Alder and Bristol-Myers Squibb that was formed in 2009 for the development of ALD518/BMS-945429....

Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com

2012-08-21 02:27:18

NEW YORK, Aug. 21, 2012 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released second quarter 2012 U.S. prescription sales data for the top 100 drugs. Proton-pump inhibitors, antipsychotics, asthma therapeutics and statins remain the top-selling categories. Plavix and Seroquel dipped in the second quarter due to loss of patent protection. Other top brands such as Singulair, Actos and Diovan are also due to be impacted by year's end. Top Five Drugs...

Plavix Patient Sues After Suffering from Traumatic Bleeding Event Allegedly While Taking Plavix

2012-08-20 23:01:48

Parker Waichman LLP has filed a lawsuit on behalf of a man who experienced hemorrhaging, allegedly due to the use of Plavix (clopidogrel). The lawsuit alleges that Plavix caused the bleeding and claims that the Defendants failed to fully inform users about the risks of taking the blood-thinning medication. New York, NY (PRWEB) August 20, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit against...

Top Searched Stocks: Molycorp, Brocade, Symantec, Bristol-Myers Squibb, Ares Capital, and Best Buy

2012-08-20 02:34:43

VANCOUVER, British Columbia, Aug. 20, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Molycorp (NYSE:MCP), Brocade (NASDAQ:BRCD), Symantec (NASDAQ:SYMC), Bristol-Myers Squibb (NYSE:BMY), Ares Capital (NASDAQ:ARCC), and Best Buy (NYSE:BBY). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...

Top Stock Alerts for Day Traders: Cisco, Seagate, AT&T, Oracle, Bristol Myers Squibb, and Barrick Gold

2012-08-13 02:29:10

VANCOUVER, British Columbia, Aug. 13, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Cisco (NASDAQ:CSCO), Seagate (NASDAQ:STX), AT&T (NYSE:T), Oracle (NASDAQ:ORCL), Bristol Myers Squibb (NYSE:BMY), and Barrick Gold (NYSE:ABX). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)...

Saladax Biomedical Enters into Master Collaboration Agreement with Bristol-Myers Squibb

2012-08-06 06:23:57

BETHLEHEM, Pa., Aug. 6, 2012 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today the company has expanded its existing relationship with Bristol-Myers Squibb Company (NYSE: BMY) by entering into a Master Early Development Collaboration Agreement, which may include multiple feasibility studies and companion diagnostic...

Most Active Stocks: Bristol Myers Squibb, Sealed Air, Symantec, Morgan Stanley, Dow Chemical, and Incyte

2012-08-03 02:26:54

VANCOUVER, British Columbia, Aug. 3, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Bristol Myers Squibb (NYSE:BMY), Sealed Air (NYSE:SEE), Symantec (NASDAQ:SYMC), Morgan Stanley (NYSE:MS), Dow Chemical (NYSE:DOW), and Incyte (NASDAQ:INCY). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...

Sanofi: As expected, Q2 2012 Business EPS(1) impacted by the loss of exclusivity of Plavix® and Avapro® in the U.S.

2012-07-26 02:29:02

PARIS, July 26, 2012 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q2 2012 Change on a Change at H1 2012 Change on a Change at reported constant reported constant basis exchange rates(1) basis exchange rates ----- ---------------- ----- -------------- Net sales...